Mercury Laboratories Limited (MERCURYLAB.BO)
INR 940.0
(2.01%)
INR 940.0
(2.01%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 78.42 Million | 24.52 Million | 51.88 Million | 82.13 Million | 54.92 Million | 52.23 Million |
| Net Income | 56.54 Million | 74.44 Million | 50.31 Million | 79.09 Million | 43.29 Million | 40.5 Million |
| Depreciation & Amortization | 28.15 Million | 24.83 Million | 24.52 Million | 19.2 Million | 18.68 Million | 16.27 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.37 Million | -67.32 Million | -8.04 Million | -8.89 Million | -2.97 Million | -5.17 Million |
| Other non-cash items | 66.32 Million | -7.42 Million | -14.9 Million | -7.26 Million | -4.07 Million | 625.05 Thousand |
| Investing Cash Flow | -62.71 Million | -10.56 Million | -18.92 Million | -46.19 Million | -11.4 Million | -49.91 Million |
| Investments in PPE | -62.71 Million | -10.56 Million | -19.14 Million | -46.19 Million | -11.4 Million | -49.91 Million |
| Acquisitions | - | - | 225 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -6.58 Million | -10.12 Million | -12.3 Million | -12.35 Million | -33.27 Million | -25.43 Million |
| Debt repayment | -1.31 Million | -2.22 Million | -12.11 Million | -861.93 Thousand | -21.75 Million | -11.93 Million |
| Dividends payments | -4.2 Million | -4.2 Million | -2.4 Million | -4.2 Million | -2.16 Million | -2.16 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 416 Thousand | -3.7 Million | 2.2 Million | -7.29 Million | -9.34 Million | -11.33 Million |
| Accounts receivables | -4.85 Million | -46.2 Million | 50.01 Million | -43.97 Million | 11.48 Million | -45.95 Million |
| Accounts payables | -12.01 Million | -4.82 Million | -49.15 Million | 33.53 Million | -32.39 Million | 27.63 Million |
| Inventory | 6.95 Million | -1.22 Million | -16.21 Million | 3.49 Million | 12.74 Million | 9.07 Million |
| Other working capital | 3.54 Million | -15.07 Million | 7.3 Million | -1.93 Million | 5.17 Million | 4.07 Million |
| Cash at beginning of period | 41.63 Million | 69.32 Million | 48.66 Million | 25.06 Million | 14.82 Million | 37.93 Million |
| Cash at end of period | 82.26 Million | 73.15 Million | 69.32 Million | 48.66 Million | 25.06 Million | 14.82 Million |
| Capital Expenditure | -62.71 Million | -10.56 Million | -19.14 Million | -46.19 Million | -11.4 Million | -49.91 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 40.63 Million | 3.82 Million | 20.66 Million | 23.59 Million | 10.24 Million | -23.11 Million |
| Free Cash Flow | 15.7 Million | 13.95 Million | 32.74 Million | 35.94 Million | 43.51 Million | 2.32 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 56.54 Million | 12.36 Million | 15.07 Million | 9.99 Million | 74.44 Million | 3.66 Million |
| Depreciation & Amortization | 28.15 Million | 7.18 Million | 7.05 Million | 6.75 Million | 24.83 Million | 6.19 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6.37 Million | - | - | - | -67.32 Million | - |
| Other non-cash items | 66.32 Million | -7.18 Million | -7.05 Million | -6.75 Million | -7.42 Million | -6.19 Million |
| Investing Cash Flow | -62.71 Million | - | - | - | -10.56 Million | - |
| Investments in PPE | -62.71 Million | - | - | - | -10.56 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -6.58 Million | - | - | - | -10.12 Million | - |
| Debt repayment | -1.31 Million | - | - | - | -2.22 Million | - |
| Dividends payments | -4.2 Million | - | - | - | -4.2 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 416 Thousand | - | - | - | -3.7 Million | - |
| Accounts receivables | -4.85 Million | - | - | - | -46.2 Million | - |
| Accounts payables | -12.01 Million | - | - | - | -4.82 Million | - |
| Inventory | 6.95 Million | - | - | - | -1.22 Million | - |
| Other working capital | 3.54 Million | - | - | - | -15.07 Million | - |
| Cash at beginning of period | 41.63 Million | 59.13 Million | 44.05 Million | 41.63 Million | 69.32 Million | 37.96 Million |
| Cash at end of period | 82.26 Million | 12.36 Million | 59.13 Million | 9.99 Million | 73.15 Million | 41.63 Million |
| Capital Expenditure | -62.71 Million | - | - | - | -10.56 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 40.63 Million | -46.76 Million | 15.07 Million | -31.63 Million | 3.82 Million | 3.66 Million |
| Free Cash Flow | 15.7 Million | 12.36 Million | 15.07 Million | 9.99 Million | 13.95 Million | 3.66 Million |
5149
ASWRF
MCM
SKT
BRVO
POLOHOT